Article
21 Nov 2025
Vera Therapeutics Submits BLA To FDA For Atacicept Fusion Protein
AUTHORS CONTENT
Article
13 Oct 2025
Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA
Article
29 Apr 2025
Celltrion Adalimumab Biosimilar Granted Interchangeability Designation
Article
11 Feb 2025
EU Biosimilar Regulatory And Launch Updates
Article
22 Nov 2024
Amgen Files BPCIA Complaint Against Accord Biopharma Regarding Denosumab Biosimilar
Article
11 Jul 2024
FDA Approves Ustekinumab, Aflibercept, And Filgrastim Biosimilars
Article
10 Jun 2024
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab
Article
05 Jun 2024
Denosumab Biosimilar Updates
Article
22 Jan 2024
Alexion Sues Samsung Over Proposed Eculizumab Biosimilar
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
03 Nov 2023
FDA Approves LOQTORZI In All Lines Of Treatment For Recurrent Or Metastatic Nasopharyngeal Carcinoma
Article
28 Sep 2023
Scheduling Order Issued In REGENXBIO v. Sarepta Litigation
Article
23 Aug 2023
Samsung Bioepis Files IPR Petition Challenging Regeneron Aflibercept Patent
Article
27 Jul 2023
FDA Accepts BLA For Dr. Reddy's Rituximab Biosimilar For Review
Article
25 Jul 2023
EMA Accepts MAA For Dong-A ST's Ustekinumab Biosimilar
Article
07 Mar 2023
USPTO Extends Deadline For Comments On USPTO-FDA Collaboration Initiatives
Article
27 Jan 2023
Alvotech And Bioventure Announce Approval Of ADALIMUMAB Biosimilar In Saudi Arabia
Article
18 Nov 2022
International Biosimilar Market Updates
Article
17 Nov 2022
Organon Launches HERCEPTIN And AVASTIN Biosimilars In Canada
Article
12 Sep 2022
Fresenius Kabi Announces FDA Approval Of Pegfilgrastim Biosimilar